Filter (Type enter to validate)
  Cat_Number Product name Supplier Quantity Price Tech More
AA0009 Signal transduction antibody array includes 165 highly specific and well-characterized antibodies in the signal transduction pathway. Abnova 2 Pieces/Box 822 AA0009 Signal transduction antibody array includes 165 highly specific and well-characterized antibodies in the signal transduction pathway. Abnova 2 Pieces/Box 822
ASK
Publication
16654-44 Geniposide[DISCONTINUED] Nacalai 30 mg 194.25 16654-44 Geniposide[DISCONTINUED] Nacalai 30 mg 194.25
ASK
Publication
CSB-E13406B Bovine Mullerian Inhibiting Substance Anti Mullerian Hormone(MIS AMH) ELISA Kit Cusabio 96T 972.3 CSB-E13406B Bovine Mullerian Inhibiting Substance Anti Mullerian Hormone(MIS AMH) ELISA Kit Cusabio 96T 972.3
ASK
Publication
03-003 Fibroblast Growth Factor 1 (FGF 1), human, active Full length recombinant mature FGF 1 (15.8 kDa, 140 amino acids) expressed in E. coli.FGF 1 (acidic FGF) is a member of the fibroblast growth factor ( B-Bridge 50 ug 253.05 03-003 Fibroblast Growth Factor 1 (FGF 1), human, active Full length recombinant mature FGF 1 (15.8 kDa, 140 amino acids) expressed in E. coli.FGF 1 (acidic FGF) is a member of the fibroblast growth factor ( B-Bridge 50 ug 253.05
ASK
Publication
03-003-5 Fibroblast Growth Factor 1 (FGF 1), human, active Full length recombinant mature FGF 1 (15.8 kDa, 140 amino acids) expressed in E. coli.FGF 1 (acidic FGF) is a member of the fibroblast growth factor ( B-Bridge 5 x 50 ug 808.5 03-003-5 Fibroblast Growth Factor 1 (FGF 1), human, active Full length recombinant mature FGF 1 (15.8 kDa, 140 amino acids) expressed in E. coli.FGF 1 (acidic FGF) is a member of the fibroblast growth factor ( B-Bridge 5 x 50 ug 808.5
ASK
Publication
51-003 removed without changing the original DNA sequence. As such, it is part of the epigenetic code and is also the most well characterized epigenetic mechanism. DNA methylation involves the addition of a B-Bridge 100 ug 253.05 51-003 removed without changing the original DNA sequence. As such, it is part of the epigenetic code and is also the most well characterized epigenetic mechanism. DNA methylation involves the addition of a B-Bridge 100 ug 253.05 Publication
11010 Signal Guard™ HRP conjugate stabilizer AAT Bioquest 50 mL 124 11010 Signal Guard™ HRP conjugate stabilizer AAT Bioquest 50 mL 124
ASK
Publication
20006 FluoroQuest™ Fluorescence Signal Enhancing Solution AAT Bioquest 5 mL 124 20006 FluoroQuest™ Fluorescence Signal Enhancing Solution AAT Bioquest 5 mL 124
ASK
Publication
CL-202 DIOGENES (SUPER OXIDE SIGNAL ENHANCER) KIT NationalDiagnostics KIT 222 CL-202 DIOGENES (SUPER OXIDE SIGNAL ENHANCER) KIT NationalDiagnostics KIT 222
ASK
Publication
Y541729 ALK FISH DNA Probe, Split Signal Dako 20 tests, 0.2 mL 1957.72 Y541729 ALK FISH DNA Probe, Split Signal Dako 20 tests, 0.2 mL 1957.72 Publication
100-170 Human Gro g Macrophage Inflammatory Protein-2 beta Gro-γ MIP-2-β CXCL3 Shenandoah Biotechnology, Inc. 2ug 113.4 100-170 Human Gro g Macrophage Inflammatory Protein-2 beta Gro-γ MIP-2-β CXCL3 Shenandoah Biotechnology, Inc. 2ug 113.4 Publication
RD172204100 Human, Allograft Inflammatory Factor-1 (AIF-1), E.coli , Rec. Prot. Biovendor 0.1 mg 352 RD172204100 Human, Allograft Inflammatory Factor-1 (AIF-1), E.coli , Rec. Prot. Biovendor 0.1 mg 352 Publication
512-A Signal Transduction Antibodies: anti-CD26 Activated T, B lymphocytes and macrophages, Clone: ICO-147 Virogen 1mg 830 512-A Signal Transduction Antibodies: anti-CD26 Activated T, B lymphocytes and macrophages, Clone: ICO-147 Virogen 1mg 830
ASK
Publication
0148-2 Expression Media Products: ACES™ Signal Sequence Kit AthenaES - GENIE Products 268 0148-2 Expression Media Products: ACES™ Signal Sequence Kit AthenaES - GENIE Products 268
ASK
Publication
066-A Signal Transduction Antibodies, anti-CD3 monoclonal antibody, Clone BD53-12 Virogen 100ug/vial 216 066-A Signal Transduction Antibodies, anti-CD3 monoclonal antibody, Clone BD53-12 Virogen 100ug/vial 216
ASK
Publication
511-A Signal Transduction Antibodies, anti-CD26 Activated T, B lymphocytes and macrophages, Clone ICO-105 Virogen 100ug/vial 216 511-A Signal Transduction Antibodies, anti-CD26 Activated T, B lymphocytes and macrophages, Clone ICO-105 Virogen 100ug/vial 216
ASK
Publication
Y050786 Anti-ACTB(Actin, cytoplasmic 1) (Beta-actin) Antibody ABM Goods 100ug 386.4 Y050786 Anti-ACTB(Actin, cytoplasmic 1) (Beta-actin) Antibody ABM Goods 100ug 386.4
ASK
Publication
bs-0637R Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Unconjugated Bioss 100ug 330 bs-0637R Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Unconjugated Bioss 100ug 330 Publication
bs-0637R-Cy3 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Cy3 Conjugated Bioss 100ug 369 bs-0637R-Cy3 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Cy3 Conjugated Bioss 100ug 369 Publication
bs-0637R-Cy5 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Cy5 Conjugated Bioss 100ug 369 bs-0637R-Cy5 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Cy5 Conjugated Bioss 100ug 369 Publication
bs-0637R-Cy5.5 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Cy5.5 Conjugated Bioss 100ug 369 bs-0637R-Cy5.5 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Cy5.5 Conjugated Bioss 100ug 369
ASK
Publication
bs-0637R-Cy7 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Cy7 Conjugated Bioss 100ug 369 bs-0637R-Cy7 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Cy7 Conjugated Bioss 100ug 369 Publication
bs-0637R-HRP Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, HRP Conjugated Bioss 100ug 369 bs-0637R-HRP Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, HRP Conjugated Bioss 100ug 369 Publication
bs-0637R-PE Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, PE Conjugated Bioss 100ug 369 bs-0637R-PE Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, PE Conjugated Bioss 100ug 369 Publication
bs-0637R-PE-Cy3 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, PE-Cy3 Conjugated Bioss 100ug 401 bs-0637R-PE-Cy3 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, PE-Cy3 Conjugated Bioss 100ug 401 Publication
bs-0637R-PE-Cy5 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, PE-Cy5 Conjugated Bioss 100ug 402 bs-0637R-PE-Cy5 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, PE-Cy5 Conjugated Bioss 100ug 402 Publication
bs-0637R-PE-Cy7 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, PE-Cy7 Conjugated Bioss 100ug 401 bs-0637R-PE-Cy7 Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, PE-Cy7 Conjugated Bioss 100ug 401 Publication
02267-41 Signal Enhancer HIKARI for Western Blotting and ELISA (50ml) Nacalai 1SET 182 02267-41 Signal Enhancer HIKARI for Western Blotting and ELISA (50ml) Nacalai 1SET 182
ASK
Publication
Y050786 Anti ACTB(Actin, cytoplasmic 1) (Beta actin) ABM Goods 100ug 436.8 Y050786 Anti ACTB(Actin, cytoplasmic 1) (Beta actin) ABM Goods 100ug 436.8
ASK
Publication
065-A Signal Transduction Antibodies, anti-CD45 RA IgG2 monoclonal antibody, Clone MYG13 Virogen 100ug/vial 216 065-A Signal Transduction Antibodies, anti-CD45 RA IgG2 monoclonal antibody, Clone MYG13 Virogen 100ug/vial 216
ASK
Publication
bs-0637R-Biotin Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Biotin Conjugated Bioss 100ug 369 bs-0637R-Biotin Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Biotin Conjugated Bioss 100ug 369 Publication
bs-0637R-Gold Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Gold Conjugated Bioss 100ug 369 bs-0637R-Gold Rabbit Anti-p38MAPK MAPK14 Polyclonal Antibody, Gold Conjugated Bioss 100ug 369 Publication
bs-1180R Rabbit Anti-RhoA Polyclonal Antibody Sepax 100ug Lyophilized 222 bs-1180R Rabbit Anti-RhoA Polyclonal Antibody Sepax 100ug Lyophilized 222
ASK
Publication
bs-1180R-Cy3 Rabbit Anti-RhoA Polyclonal Antibody, Cy3 Conjugated Bioss 100ug 369 bs-1180R-Cy3 Rabbit Anti-RhoA Polyclonal Antibody, Cy3 Conjugated Bioss 100ug 369
ASK
Publication
bs-1180R-Cy5 Rabbit Anti-RhoA Polyclonal Antibody, Cy5 Conjugated Bioss 100ug 369 bs-1180R-Cy5 Rabbit Anti-RhoA Polyclonal Antibody, Cy5 Conjugated Bioss 100ug 369
ASK
Publication
bs-1180R-Cy5.5 Rabbit Anti-RhoA Polyclonal Antibody, Cy5.5 Conjugated Bioss 100ug 369 bs-1180R-Cy5.5 Rabbit Anti-RhoA Polyclonal Antibody, Cy5.5 Conjugated Bioss 100ug 369
ASK
Publication
bs-1180R-Cy7 Rabbit Anti-RhoA Polyclonal Antibody, Cy7 Conjugated Bioss 100ug 369 bs-1180R-Cy7 Rabbit Anti-RhoA Polyclonal Antibody, Cy7 Conjugated Bioss 100ug 369
ASK
Publication
bs-1180R-HRP Rabbit Anti-RhoA Polyclonal Antibody, HRP Conjugated Bioss 100ug 369 bs-1180R-HRP Rabbit Anti-RhoA Polyclonal Antibody, HRP Conjugated Bioss 100ug 369
ASK
Publication
bs-1180R-PE Rabbit Anti-RhoA Polyclonal Antibody, PE Conjugated Bioss 100ug 369 bs-1180R-PE Rabbit Anti-RhoA Polyclonal Antibody, PE Conjugated Bioss 100ug 369
ASK
Publication
bs-1180R-PE-Cy3 Rabbit Anti-RhoA Polyclonal Antibody, PE-Cy3 Conjugated Bioss 100ug 401 bs-1180R-PE-Cy3 Rabbit Anti-RhoA Polyclonal Antibody, PE-Cy3 Conjugated Bioss 100ug 401
ASK
Publication
bs-1180R-PE-Cy5 Rabbit Anti-RhoA Polyclonal Antibody, PE-Cy5 Conjugated Bioss 100ug 402 bs-1180R-PE-Cy5 Rabbit Anti-RhoA Polyclonal Antibody, PE-Cy5 Conjugated Bioss 100ug 402
ASK
Publication
bs-1180R-PE-Cy7 Rabbit Anti-RhoA Polyclonal Antibody, PE-Cy7 Conjugated Bioss 100ug 401 bs-1180R-PE-Cy7 Rabbit Anti-RhoA Polyclonal Antibody, PE-Cy7 Conjugated Bioss 100ug 401
ASK
Publication
bs-1180R-Alexa488 Rabbit Anti-RhoA Polyclonal Antibody, Alexa 488 Conjugated Bioss 100ug 369 bs-1180R-Alexa488 Rabbit Anti-RhoA Polyclonal Antibody, Alexa 488 Conjugated Bioss 100ug 369
ASK
Publication
bs-1180R-Biotin Rabbit Anti-RhoA Polyclonal Antibody, Biotin Conjugated Bioss 100ug 369 bs-1180R-Biotin Rabbit Anti-RhoA Polyclonal Antibody, Biotin Conjugated Bioss 100ug 369
ASK
Publication
bs-0637R-PE-Cy5.5 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-0637R-PE-Cy5.5 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300
ASK
Publication
bs-1180R-PE-Cy5.5 Rabbit Anti-RhoA Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-1180R-PE-Cy5.5 Rabbit Anti-RhoA Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300
ASK
Publication
bs-0637R-FITC Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 bs-0637R-FITC Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 Publication
bs-1180R-FITC Rabbit Anti-RhoA Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 bs-1180R-FITC Rabbit Anti-RhoA Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304
ASK
Publication
079-A Signal Transduction Antibodies, anti-p53, clone BP53-12, Clone IPO-38 Virogen 100ug/vial 216 079-A Signal Transduction Antibodies, anti-p53, clone BP53-12, Clone IPO-38 Virogen 100ug/vial 216
ASK
Publication
bs-0637R-A350 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0637R-A350 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-0637R-A488 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0637R-A488 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-0637R-A555 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0637R-A555 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-0637R-A647 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0637R-A647 Rabbit Anti-p38MAPK MAPK14 p38Alpha Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-1180R-A350 Rabbit Anti-RhoA Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-1180R-A350 Rabbit Anti-RhoA Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323
ASK
Publication
bs-1180R-A555 Rabbit Anti-RhoA Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-1180R-A555 Rabbit Anti-RhoA Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323
ASK
Publication
bs-1180R-A647 Rabbit Anti-RhoA Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-1180R-A647 Rabbit Anti-RhoA Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323
ASK
Publication
E11F0250 Bovine anti-Fibroblast surface protein BlueGen 96 Tests/kit 1128 E11F0250 Bovine anti-Fibroblast surface protein BlueGen 96 Tests/kit 1128 Publication
300-27 Rat Fibroblast Growth Factor-9 FGF-9 Shenandoah Biotechnology, Inc. 2ug 113.4 300-27 Rat Fibroblast Growth Factor-9 FGF-9 Shenandoah Biotechnology, Inc. 2ug 113.4 Publication
100-134 Human Macrophage Inflammatory Protein-1 beta (CCL4) MIP-1 β CCL4 Shenandoah Biotechnology, Inc. 2ug 113.4 100-134 Human Macrophage Inflammatory Protein-1 beta (CCL4) MIP-1 β CCL4 Shenandoah Biotechnology, Inc. 2ug 113.4 Publication
100-135 Human Macrophage Inflammatory Protein-3 beta (CCL19) MIP-3 β CCL19 Shenandoah Biotechnology, Inc. 5ug 113.4 100-135 Human Macrophage Inflammatory Protein-3 beta (CCL19) MIP-3 β CCL19 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
100-147 Human Macrophage Inflammatory Protein-3 alpha (CCL20) MIP-3 α CCL20 Shenandoah Biotechnology, Inc. 5ug 113.4 100-147 Human Macrophage Inflammatory Protein-3 alpha (CCL20) MIP-3 α CCL20 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
100-15 Human Macrophage Inflammatory Protein-1 alpha (CCL3) MIP-1 α CCL3 Shenandoah Biotechnology, Inc. 5ug 113.4 100-15 Human Macrophage Inflammatory Protein-1 alpha (CCL3) MIP-1 α CCL3 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
200-42 Mouse Macrophage Inflammatory Protein-1 alpha (CCL3) MIP-1 α CCL3 Shenandoah Biotechnology, Inc. 2ug 113.4 200-42 Mouse Macrophage Inflammatory Protein-1 alpha (CCL3) MIP-1 α CCL3 Shenandoah Biotechnology, Inc. 2ug 113.4 Publication
200-43 Mouse Macrophage Inflammatory Protein-1 beta (CCL4) MIP-1 β CCL4 Shenandoah Biotechnology, Inc. 2ug 113.4 200-43 Mouse Macrophage Inflammatory Protein-1 beta (CCL4) MIP-1 β CCL4 Shenandoah Biotechnology, Inc. 2ug 113.4 Publication
200-44 Mouse Macrophage Inflammatory Protein-3 beta (CCL19) MIP-3 β CCL19 Shenandoah Biotechnology, Inc. 5ug 113.4 200-44 Mouse Macrophage Inflammatory Protein-3 beta (CCL19) MIP-3 β CCL19 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
200-51 Mouse Macrophage Inflammatory Protein-3 alpha (CCL20) MIP-3 α CCL20 Shenandoah Biotechnology, Inc. 5ug 113.4 200-51 Mouse Macrophage Inflammatory Protein-3 alpha (CCL20) MIP-3 α CCL20 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
1659-1 Hh Signaling Pathway Antagonist Biovision 1 mg 162 1659-1 Hh Signaling Pathway Antagonist Biovision 1 mg 162 Publication
RD181107100 Rabbit Polyclonal Antibody; Fibroblast Growth Factor 19, Anti-Human Biovendor 0.1 mg 258 RD181107100 Rabbit Polyclonal Antibody; Fibroblast Growth Factor 19, Anti-Human Biovendor 0.1 mg 258 Publication
RD181108100 Rabbit Polyclonal Antibody; Fibroblast Growth Factor 21, Anti-Human Biovendor 0.1 mg 258 RD181108100 Rabbit Polyclonal Antibody; Fibroblast Growth Factor 21, Anti-Human Biovendor 0.1 mg 258 Publication
RD181109100-01 Rabbit Polyclonal Antibody; Fibroblast Growth Factor 23, Anti-Human Biovendor 0.1 mg 258 RD181109100-01 Rabbit Polyclonal Antibody; Fibroblast Growth Factor 23, Anti-Human Biovendor 0.1 mg 258 Publication
RD184107100 Sheep Polyclonal Antibody; Fibroblast Growth Factor 19, Anti-Human Biovendor 0.1 mg 239 RD184107100 Sheep Polyclonal Antibody; Fibroblast Growth Factor 19, Anti-Human Biovendor 0.1 mg 239 Publication
RD184108100 Sheep Polyclonal Antibody; Fibroblast Growth Factor 21, Anti-Human Biovendor 0.1 mg 239 RD184108100 Sheep Polyclonal Antibody; Fibroblast Growth Factor 21, Anti-Human Biovendor 0.1 mg 239 Publication
RD281108100 Rabbit Polyclonal Antibody; Fibroblast Growth Factor 21, Anti-Mouse Biovendor 0.1 mg 258 RD281108100 Rabbit Polyclonal Antibody; Fibroblast Growth Factor 21, Anti-Mouse Biovendor 0.1 mg 258 Publication
100-148 Human Fibroblast Growth Factor-21 FGF-21 Shenandoah Biotechnology, Inc. 5ug 113.4 100-148 Human Fibroblast Growth Factor-21 FGF-21 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
100-31 Human Fibroblast Growth Factor-4 FGF-4 Shenandoah Biotechnology, Inc. 5ug 113.4 100-31 Human Fibroblast Growth Factor-4 FGF-4 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
100-68 Human Fibroblast Growth Factor-22 FGF-22 Shenandoah Biotechnology, Inc. 5ug 113.4 100-68 Human Fibroblast Growth Factor-22 FGF-22 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
200-13 Mouse Fibroblast Growth Factor 9 FGF-9 Shenandoah Biotechnology, Inc. 2ug 113.4 200-13 Mouse Fibroblast Growth Factor 9 FGF-9 Shenandoah Biotechnology, Inc. 2ug 113.4 Publication
100-136 Human Macrophage Inflammatory Protein-4 (CCL18) MIP-4 CCL18 Shenandoah Biotechnology, Inc. 2ug 113.4 100-136 Human Macrophage Inflammatory Protein-4 (CCL18) MIP-4 CCL18 Shenandoah Biotechnology, Inc. 2ug 113.4 Publication
300-23 Rat Macrophage Inflammatory Protein-1 alpha (CCL3) MIP-1 α CCL3 Shenandoah Biotechnology, Inc. 5ug 113.4 300-23 Rat Macrophage Inflammatory Protein-1 alpha (CCL3) MIP-1 α CCL3 Shenandoah Biotechnology, Inc. 5ug 113.4 Publication
ER-14-0544 Goat Anti-Human Fibroblast growth factor 21, (internal region) Antibodies Ray Biotech 100 μg 353 ER-14-0544 Goat Anti-Human Fibroblast growth factor 21, (internal region) Antibodies Ray Biotech 100 μg 353
ASK
Publication
03-003 Fibroblast Growth Factor 1 (FGF 1), human, active B-Bridge 50 ug 308.438 03-003 Fibroblast Growth Factor 1 (FGF 1), human, active B-Bridge 50 ug 308.438
ASK
Publication
03-003-5 Fibroblast Growth Factor 1 (FGF 1), human, active B-Bridge 5 x 50 ug 871.5 03-003-5 Fibroblast Growth Factor 1 (FGF 1), human, active B-Bridge 5 x 50 ug 871.5
ASK
Publication
E11F0250 Bovine Fibroblast surface protein Other suppliers 96 Tests/kit 789 E11F0250 Bovine Fibroblast surface protein Other suppliers 96 Tests/kit 789 Publication
E11F0250 Bovine Fibroblast surface protein ELISA, FSP Blue Gene Biotech 715 E11F0250 Bovine Fibroblast surface protein ELISA, FSP Blue Gene Biotech 715 Publication
RD172108100 Human, Fibroblast Growth Factor 21 , Rec. Prot. Biovendor 0.1 mg 313 RD172108100 Human, Fibroblast Growth Factor 21 , Rec. Prot. Biovendor 0.1 mg 313 Publication
RD172108100-B Human, Fibroblast Growth Factor 21 , Rec. Prot. Biovendor 0.1 mg 313 RD172108100-B Human, Fibroblast Growth Factor 21 , Rec. Prot. Biovendor 0.1 mg 313 Publication
RD272108100 Mouse, Fibroblast Growth Factor 21 , Rec. Prot. Biovendor 0.1 mg 313 RD272108100 Mouse, Fibroblast Growth Factor 21 , Rec. Prot. Biovendor 0.1 mg 313 Publication
RD272108100-B Mouse, Fibroblast Growth Factor 21 , Rec. Prot. Biovendor 0.1 mg 313 RD272108100-B Mouse, Fibroblast Growth Factor 21 , Rec. Prot. Biovendor 0.1 mg 313 Publication
ER-14-1460 Goat Anti-Human Tissue Factor Pathway Inhibitor, (C Terminus) Antibodies Ray Biotech 100 μg 353 ER-14-1460 Goat Anti-Human Tissue Factor Pathway Inhibitor, (C Terminus) Antibodies Ray Biotech 100 μg 353
ASK
Publication
RD172107100 Human, Fibroblast Growth Factor 19, E.coli , Rec. Prot. Biovendor 0.1 mg 313 RD172107100 Human, Fibroblast Growth Factor 19, E.coli , Rec. Prot. Biovendor 0.1 mg 313 Publication
RD191107200R ELISA Human , Fibroblast Growth Factor 19 Biovendor 96 wells (1 kit) 456 RD191107200R ELISA Human , Fibroblast Growth Factor 19 Biovendor 96 wells (1 kit) 456 Publication
RD191108200R ELISA Human , Fibroblast Growth Factor 21 Biovendor 96 wells (1 kit) 553 RD191108200R ELISA Human , Fibroblast Growth Factor 21 Biovendor 96 wells (1 kit) 553 Publication
RD291108200R ELISA Mouse Rat , Fibroblast Growth Factor 21 Biovendor 96 wells (1 kit) 695 RD291108200R ELISA Mouse Rat , Fibroblast Growth Factor 21 Biovendor 96 wells (1 kit) 695 Publication
60406 SRE Reporter - HEK293 Cell Line (ERK Pathway) BPS Bioscience 1.5 x 10^6 cells 2598 60406 SRE Reporter - HEK293 Cell Line (ERK Pathway) BPS Bioscience 1.5 x 10^6 cells 2598
ASK
Publication
NRPC03A Recombinant Human Fibroblast Growth Factor-basic rh-bFGF NTec 2ug x 20 151 NRPC03A Recombinant Human Fibroblast Growth Factor-basic rh-bFGF NTec 2ug x 20 151
ASK
Publication
60405 AP-1 Reporter – HEK293 Cell Line (JNK signaling pathway) BPS Bioscience 1.5 x 10^6 cells 2598 60405 AP-1 Reporter – HEK293 Cell Line (JNK signaling pathway) BPS Bioscience 1.5 x 10^6 cells 2598
ASK
Publication
60409 Gli Reporter – NIH3T3 Cell line (Hedgehog Pathway) BPS Bioscience 500 reactions 6420 60409 Gli Reporter – NIH3T3 Cell line (Hedgehog Pathway) BPS Bioscience 500 reactions 6420
ASK
Publication
60510 JAK pathway ISRE reporter cell line BPS Bioscience 1.5x10(6) cells 6420 60510 JAK pathway ISRE reporter cell line BPS Bioscience 1.5x10(6) cells 6420
ASK
Publication
60513 Nrf antioxidant pathway ARE reporter cell line BPS Bioscience 1.5x10(6) cells 6420 60513 Nrf antioxidant pathway ARE reporter cell line BPS Bioscience 1.5x10(6) cells 6420
ASK
Publication
RD172241100 Human, Fibroblast Growth Factor 23 C-terminal peptide, E.coli , Rec. Prot. Biovendor 0.1 mg 313 RD172241100 Human, Fibroblast Growth Factor 23 C-terminal peptide, E.coli , Rec. Prot. Biovendor 0.1 mg 313 Publication
60501 Wnt Signaling Pathway TCF LEF reporter-HEK293 stable cell line BPS Bioscience 1.5x10(6) cells 6420 60501 Wnt Signaling Pathway TCF LEF reporter-HEK293 stable cell line BPS Bioscience 1.5x10(6) cells 6420
ASK
Publication
DI0320 MAPK8 & RHOA Protein Protein Interaction Antibody Pair Abnova 1 Set 765 DI0320 MAPK8 & RHOA Protein Protein Interaction Antibody Pair Abnova 1 Set 765
ASK
Publication
DI0473 FADD & RHOA Protein Protein Interaction Antibody Pair Abnova 1 Set 765 DI0473 FADD & RHOA Protein Protein Interaction Antibody Pair Abnova 1 Set 765
ASK
Publication
DI0603 RHOA & DAAM1 Protein Protein Interaction Antibody Pair Abnova 1 Set 765 DI0603 RHOA & DAAM1 Protein Protein Interaction Antibody Pair Abnova 1 Set 765
ASK
Publication
DI0454 FAS & RHOA Protein Protein Interaction Antibody Pair Abnova 1 Set 765 DI0454 FAS & RHOA Protein Protein Interaction Antibody Pair Abnova 1 Set 765
ASK
Publication
DI0472 BID & RHOA Protein Protein Interaction Antibody Pair Abnova 1 Set 765 DI0472 BID & RHOA Protein Protein Interaction Antibody Pair Abnova 1 Set 765
ASK
Publication
Y051597 to FAPβ (Fibroblast Activation Protein alpha subunit, Seprase, Integral Membrane Serine Protease) Stalk Region ABM Goods 100μg 916.65 Y051597 to FAPβ (Fibroblast Activation Protein alpha subunit, Seprase, Integral Membrane Serine Protease) Stalk Region ABM Goods 100μg 916.65
ASK
Publication
Y051597 to FAPβ (Fibroblast Activation Protein alpha subunit, Seprase, Integral Membrane Serine Protease) Stalk Region Antibody ABM Goods 100μg 811.65 Y051597 to FAPβ (Fibroblast Activation Protein alpha subunit, Seprase, Integral Membrane Serine Protease) Stalk Region Antibody ABM Goods 100μg 811.65
ASK
Publication
100-146 Human Fibroblast Growth Factor 154 basic FGF-basic 154 Shenandoah Biotechnology, Inc. 10ug 113.4 100-146 Human Fibroblast Growth Factor 154 basic FGF-basic 154 Shenandoah Biotechnology, Inc. 10ug 113.4 Publication
100-28 Human Fibroblast Growth Factor 147 basic FGF-basic 147 Shenandoah Biotechnology, Inc. 10ug 113.4 100-28 Human Fibroblast Growth Factor 147 basic FGF-basic 147 Shenandoah Biotechnology, Inc. 10ug 113.4 Publication
100-29 Human Fibroblast Growth Factor acidic FGF-acidic Shenandoah Biotechnology, Inc. 10ug 113.4 100-29 Human Fibroblast Growth Factor acidic FGF-acidic Shenandoah Biotechnology, Inc. 10ug 113.4 Publication
200-12 Mouse Fibroblast Growth Factor basic FGF-basic Shenandoah Biotechnology, Inc. 10ug 113.4 200-12 Mouse Fibroblast Growth Factor basic FGF-basic Shenandoah Biotechnology, Inc. 10ug 113.4 Publication
200-48 Mouse Fibroblast Growth Factor acidic FGF-acidic Shenandoah Biotechnology, Inc. 10ug 113.4 200-48 Mouse Fibroblast Growth Factor acidic FGF-acidic Shenandoah Biotechnology, Inc. 10ug 113.4 Publication
AA0002 Apoptosis antibody array includes 73 highly specific and well-characterized antibodies in the apoptosis pathway. Abnova 2 Pieces/Box 731 AA0002 Apoptosis antibody array includes 73 highly specific and well-characterized antibodies in the apoptosis pathway. Abnova 2 Pieces/Box 731
ASK
Publication
AA0005 Cytokine antibody array includes 77 highly specific and well-characterized antibodies in the cytokine pathway. Abnova 2 Pieces/Box 731 AA0005 Cytokine antibody array includes 77 highly specific and well-characterized antibodies in the cytokine pathway. Abnova 2 Pieces/Box 731
ASK
Publication
AA0012 AKT Phospho-Specific Array includes 137 highly specific and well-characterized phosphorylation antibodies in the AKT pathway. Abnova 2 Pieces/Box 776 AA0012 AKT Phospho-Specific Array includes 137 highly specific and well-characterized phosphorylation antibodies in the AKT pathway. Abnova 2 Pieces/Box 776
ASK
Publication
AA0035 NF-kB Phospho-Specific Array includes 63 highly specific and well-characterized phosphorylation antibodies in the NF-kB pathway. Abnova 2 Pieces/Box 731 AA0035 NF-kB Phospho-Specific Array includes 63 highly specific and well-characterized phosphorylation antibodies in the NF-kB pathway. Abnova 2 Pieces/Box 731
ASK
Publication
AA0025 ERK Signaling Phospho-Specific Array includes 208 highly specific and well-characterized phosphorylation antibodies in the ERK pathway. Abnova 2 Pieces/Box 822 AA0025 ERK Signaling Phospho-Specific Array includes 208 highly specific and well-characterized phosphorylation antibodies in the ERK pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0036 NF-kB II Phospho-Specific Array includes 215 highly specific and well-characterized phosphorylation antibodies in the NF-kB signaling pathway. Abnova 2 Pieces/Box 822 AA0036 NF-kB II Phospho-Specific Array includes 215 highly specific and well-characterized phosphorylation antibodies in the NF-kB signaling pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0021 Cytoskeleton Phospho-Specific Array includes 95 highly specific and well-characterized phosphorylation antibodies in the cytoskeletal pathway. Abnova 2 Pieces/Box 731 AA0021 Cytoskeleton Phospho-Specific Array includes 95 highly specific and well-characterized phosphorylation antibodies in the cytoskeletal pathway. Abnova 2 Pieces/Box 731
ASK
Publication
AA0022 Cytoskeleton II Phospho-Specific Array includes 141 highly specific and well-characterized phosphorylation antibodies in the cytoskeletal pathway. Abnova 2 Pieces/Box 776 AA0022 Cytoskeleton II Phospho-Specific Array includes 141 highly specific and well-characterized phosphorylation antibodies in the cytoskeletal pathway. Abnova 2 Pieces/Box 776
ASK
Publication
K868-6 DiscoveryPak™ Hedgehog (Hh) Signaling Pathway Inhibitors Set Biovision Inhibitors 513 K868-6 DiscoveryPak™ Hedgehog (Hh) Signaling Pathway Inhibitors Set Biovision Inhibitors 513 Publication
M1582 pCAMBIA0305.2 Vector (Secreted GusPlus™No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance, GusPlus™, GRP signal pepti MarkerGene 186 M1582 pCAMBIA0305.2 Vector (Secreted GusPlus™No Bacterial Selection Kanamycin Resistant Plant Expression Vector), pUC18 poly-linker, no plant selection gene, kanamycin resistance, GusPlus™, GRP signal pepti MarkerGene 186
ASK
Publication
AA0004 Cell cycle antibody array includes 60 highly specific and well-characterized antibodies in the cell cycle pathway. Abnova 2 Pieces/Box 731 AA0004 Cell cycle antibody array includes 60 highly specific and well-characterized antibodies in the cell cycle pathway. Abnova 2 Pieces/Box 731
ASK
Publication
AA0013 AKT PKB Signaling Phospho-Specific Array includes 216 highly specific and well-characterized phosphorylation antibodies in the AKT PKB signaling pathway. Abnova 2 Pieces/Box 822 AA0013 AKT PKB Signaling Phospho-Specific Array includes 216 highly specific and well-characterized phosphorylation antibodies in the AKT PKB signaling pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0020 CREB Phospho-Specific Array includes 174 highly specific and well-characterized phosphorylation antibodies in the CREB pathway. Abnova 2 Pieces/Box 822 AA0020 CREB Phospho-Specific Array includes 174 highly specific and well-characterized phosphorylation antibodies in the CREB pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0031 Jak Stat Phospho-Specific Array includes 42 highly specific and well-characterized phosphorylation antibodies in the Jak Stat pathway. Abnova 2 Pieces/Box 598 AA0031 Jak Stat Phospho-Specific Array includes 42 highly specific and well-characterized phosphorylation antibodies in the Jak Stat pathway. Abnova 2 Pieces/Box 598
ASK
Publication
AA0032 Jak Stat II Phospho-Specific Array includes 202 highly specific and well-characterized phosphorylation antibodies in the Jak Stat pathway. Abnova 2 Pieces/Box 822 AA0032 Jak Stat II Phospho-Specific Array includes 202 highly specific and well-characterized phosphorylation antibodies in the Jak Stat pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0033 MAPK Phospho-Specific Array includes 185 highly specific and well-characterized phosphorylation antibodies in the MAPK pathway. Abnova 2 Pieces/Box 822 AA0033 MAPK Phospho-Specific Array includes 185 highly specific and well-characterized phosphorylation antibodies in the MAPK pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0038 p53 Signaling Phospho-Specific Array includes 196 highly specific and well-characterized phosphorylation antibodies in the p53 signaling pathway. Abnova 2 Pieces/Box 822 AA0038 p53 Signaling Phospho-Specific Array includes 196 highly specific and well-characterized phosphorylation antibodies in the p53 signaling pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0039 PDGF Phospho-Specific Array includes 195 highly specific and well-characterized phosphorylation antibodies in the PDGF pathway. Abnova 2 Pieces/Box 822 AA0039 PDGF Phospho-Specific Array includes 195 highly specific and well-characterized phosphorylation antibodies in the PDGF pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0024 ErbB Her Signaling Phospho-Specific Array includes 239 highly specific and well-characterized phosphorylation antibodies in the ErbB Her pathway. Abnova 2 Pieces/Box 822 AA0024 ErbB Her Signaling Phospho-Specific Array includes 239 highly specific and well-characterized phosphorylation antibodies in the ErbB Her pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0034 mTOR Signalign Phospho-Specific Array includes 138 highly specific and well-characterized phosphorylation antibodies in the mTOR ignaling pathway. Abnova 2 Pieces/Box 776 AA0034 mTOR Signalign Phospho-Specific Array includes 138 highly specific and well-characterized phosphorylation antibodies in the mTOR ignaling pathway. Abnova 2 Pieces/Box 776
ASK
Publication
AA0027 GPCR Signaling to MAPK ERk Phospho-Specific Array includes 193 highly specific and well-characterized phosphorylation antibodies related to this signaling pathway. Abnova 2 Pieces/Box 822 AA0027 GPCR Signaling to MAPK ERk Phospho-Specific Array includes 193 highly specific and well-characterized phosphorylation antibodies related to this signaling pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0028 IGF-1R Signaling Phospho-Specific Array includes 245 highly specific and well-characterized phosphorylation antibodies in the insulin-like growth factor 1 receptor signaling pathway. Abnova 2 Pieces/Box 822 AA0028 IGF-1R Signaling Phospho-Specific Array includes 245 highly specific and well-characterized phosphorylation antibodies in the insulin-like growth factor 1 receptor signaling pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0014 AMPK Signaling Phospho-Specific Array includes 174 highly specific and well-characterized phosphorylation antibodies in the AMPK signaling pathway. Abnova 2 Pieces/Box 822 AA0014 AMPK Signaling Phospho-Specific Array includes 174 highly specific and well-characterized phosphorylation antibodies in the AMPK signaling pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0016 Cancer Apoptosis Phospho-Specific Array includes 155 highly specific and well-characterized phosphorylation antibodies in the Cancer Apoptosis pathway. Abnova 2 Pieces/Box 822 AA0016 Cancer Apoptosis Phospho-Specific Array includes 155 highly specific and well-characterized phosphorylation antibodies in the Cancer Apoptosis pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0018 Cell Cycle Phospho-Specific Array includes 76 highly specific and well-characterized phosphorylation antibodies in the Cell Cycle pathway. Abnova 2 Pieces/Box 731 AA0018 Cell Cycle Phospho-Specific Array includes 76 highly specific and well-characterized phosphorylation antibodies in the Cell Cycle pathway. Abnova 2 Pieces/Box 731
ASK
Publication
AA0019 Chromatin Transcription Phospho-Specific Array includes 173 highly specific and well-characterized phosphorylation antibodies in the Chromatin Transcription pathway. Abnova 2 Pieces/Box 822 AA0019 Chromatin Transcription Phospho-Specific Array includes 173 highly specific and well-characterized phosphorylation antibodies in the Chromatin Transcription pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0029 Insulin Receptor Phospho-Specific Array includes 219 highly specific and well-characterized phosphorylation antibodies in the insulin receptor pathway. Abnova 2 Pieces/Box 822 AA0029 Insulin Receptor Phospho-Specific Array includes 219 highly specific and well-characterized phosphorylation antibodies in the insulin receptor pathway. Abnova 2 Pieces/Box 822
ASK
Publication
AA0030 Insulin Glucose Phospho-Specific Array includes 85 highly specific and well-characterized phosphorylation antibodies in the insulin glucose pathway. Abnova 2 Pieces/Box 731 AA0030 Insulin Glucose Phospho-Specific Array includes 85 highly specific and well-characterized phosphorylation antibodies in the insulin glucose pathway. Abnova 2 Pieces/Box 731
ASK
Publication
AA0041 TGF-Beta Signaling Phospho-Specific Array includes 176 highly specific and well-characterized phosphorylation antibodies in the TGF-Beta signaling pathway. Abnova 2 Pieces/Box 822 AA0041 TGF-Beta Signaling Phospho-Specific Array includes 176 highly specific and well-characterized phosphorylation antibodies in the TGF-Beta signaling pathway. Abnova 2 Pieces/Box 822
ASK
Publication
E0552h ELISA kit CLGI,Collagenase inhibitor,EPA,Erythroid-potentiating activity,Fibroblast collagenase inhibitor,Homo sapiens,Human,Metalloproteinase inhibitor 1,TIMP,TIMP1,TIMP-1,Tissue inhibitor of metall EIAab 96T 706.65 E0552h ELISA kit CLGI,Collagenase inhibitor,EPA,Erythroid-potentiating activity,Fibroblast collagenase inhibitor,Homo sapiens,Human,Metalloproteinase inhibitor 1,TIMP,TIMP1,TIMP-1,Tissue inhibitor of metall EIAab 96T 706.65
ASK
Publication
Y090121 Anti Actin Monoclonal ABM Goods 100ul 299.25 Y090121 Anti Actin Monoclonal ABM Goods 100ul 299.25
ASK
Publication
AA0040 T-Cell Receptor Signaling Phospho-Specific Array includes 188 highly specific and well-characterized phosphorylation antibodies in the T-cell receptor signaling pathway. Abnova 2 Pieces/Box 822 AA0040 T-Cell Receptor Signaling Phospho-Specific Array includes 188 highly specific and well-characterized phosphorylation antibodies in the T-cell receptor signaling pathway. Abnova 2 Pieces/Box 822
ASK
Publication
130-10038-200 Rabbit Anti-Human Actin (SMA) Antibodies Ray Biotech 200 211 130-10038-200 Rabbit Anti-Human Actin (SMA) Antibodies Ray Biotech 200 211 Publication
DS-MB-00012 Mouse Anti-Human Actin (Muscle) Ray Biotech 1 mL 793 DS-MB-00012 Mouse Anti-Human Actin (Muscle) Ray Biotech 1 mL 793
ASK
Publication
DS-MB-00013 Mouse Anti-Human Actin (Muscle) Ray Biotech 6 mL 717 DS-MB-00013 Mouse Anti-Human Actin (Muscle) Ray Biotech 6 mL 717
ASK
Publication
DS-MB-00014 Mouse Anti-Human Actin (Muscle) Ray Biotech 100 276 DS-MB-00014 Mouse Anti-Human Actin (Muscle) Ray Biotech 100 276
ASK
Publication
DS-PB-00066 Rabbit Anti-Actin (Muscle) Antibodies Ray Biotech 0.5 ml 510 DS-PB-00066 Rabbit Anti-Actin (Muscle) Antibodies Ray Biotech 0.5 ml 510
ASK
Publication
Y061027 Anti Actin (20 33) produced in rabbit ABM Goods 100ul 964.95 Y061027 Anti Actin (20 33) produced in rabbit ABM Goods 100ul 964.95
ASK
Publication
Y061029 Anti Actin produced in rabbit ABM Goods 100ul 964.95 Y061029 Anti Actin produced in rabbit ABM Goods 100ul 964.95
ASK
Publication
Y061030 Anti Actin produced in rabbit ABM Goods 100ul 964.95 Y061030 Anti Actin produced in rabbit ABM Goods 100ul 964.95
ASK
Publication
Y090121 Anti-Actin Monoclonal Antibody ABM Goods 100ul 265.65 Y090121 Anti-Actin Monoclonal Antibody ABM Goods 100ul 265.65
ASK
Publication
Y090724 Anti actin associated antigen Monoclonal ABM Goods 100ul 299.25 Y090724 Anti actin associated antigen Monoclonal ABM Goods 100ul 299.25
ASK
Publication
129-10012 Rabbit Anti-Human Actin beta, N-terminus Ray Biotech 100 528 129-10012 Rabbit Anti-Human Actin beta, N-terminus Ray Biotech 100 528
ASK
Publication
130-10038-1000 Rabbit Anti-Human Actin (SMA) Antibodies Ray Biotech 1000 517 130-10038-1000 Rabbit Anti-Human Actin (SMA) Antibodies Ray Biotech 1000 517 Publication
DS-MB-00015 Mouse Anti-Human Actin (Sarcomeric) Antibodies Ray Biotech 5 ml 452 DS-MB-00015 Mouse Anti-Human Actin (Sarcomeric) Antibodies Ray Biotech 5 ml 452 Publication
DS-MB-00020 Mouse Anti-Human Actin, filamentous Antibodies Ray Biotech 0.5 mg 411 DS-MB-00020 Mouse Anti-Human Actin, filamentous Antibodies Ray Biotech 0.5 mg 411 Publication
DS-MB-00021 Mouse Anti-Human Actin, filamentous Antibodies Ray Biotech 50 309 DS-MB-00021 Mouse Anti-Human Actin, filamentous Antibodies Ray Biotech 50 309 Publication
Y061017 Monoclonal Anti Actin produced in mouse ABM Goods 100ul 1119.3 Y061017 Monoclonal Anti Actin produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
Y061019 Monoclonal Anti Actin Cy3 produced in mouse ABM Goods 100ul 1119.3 Y061019 Monoclonal Anti Actin Cy3 produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
Y061027 Anti-Actin (20-33) produced in rabbit Antibody ABM Goods 100ul 857.85 Y061027 Anti-Actin (20-33) produced in rabbit Antibody ABM Goods 100ul 857.85
ASK
Publication
Y061028 Anti Actin, N terminal produced in rabbit ABM Goods 100ul 964.95 Y061028 Anti Actin, N terminal produced in rabbit ABM Goods 100ul 964.95
ASK
Publication
Y061029 Anti-Actin produced in rabbit Antibody ABM Goods 100ul 857.85 Y061029 Anti-Actin produced in rabbit Antibody ABM Goods 100ul 857.85
ASK
Publication
Y061030 Anti-Actin produced in rabbit Antibody ABM Goods 100ul 857.85 Y061030 Anti-Actin produced in rabbit Antibody ABM Goods 100ul 857.85
ASK
Publication
Y090087 Anti actin binding protein 34 (ABP34) ABM Goods 100ul 299.25 Y090087 Anti actin binding protein 34 (ABP34) ABM Goods 100ul 299.25
ASK
Publication
Y090724 Anti-actin associated antigen Monoclonal Antibody ABM Goods 100ul 265.65 Y090724 Anti-actin associated antigen Monoclonal Antibody ABM Goods 100ul 265.65
ASK
Publication
228-10021-2 Actin Ray Biotech 50 290 228-10021-2 Actin Ray Biotech 50 290
ASK
Publication
228-10021-3 Actin Ray Biotech 1 mg 2509 228-10021-3 Actin Ray Biotech 1 mg 2509
ASK
Publication
ER-14-0085 Goat Anti-Human Actin-like 7B, (internal region) Antibodies Ray Biotech 100 μg 353 ER-14-0085 Goat Anti-Human Actin-like 7B, (internal region) Antibodies Ray Biotech 100 μg 353
ASK
Publication
ER-14-0086 Goat Anti-Rat Actin-like 7B (mouse), (internal region) Antibodies Ray Biotech 100 μg 353 ER-14-0086 Goat Anti-Rat Actin-like 7B (mouse), (internal region) Antibodies Ray Biotech 100 μg 353
ASK
Publication
iAP-0002 Mouse anti beta actin (HRP) Loading control antibodies AngoiPro 100.00 ul 284 iAP-0002 Mouse anti beta actin (HRP) Loading control antibodies AngoiPro 100.00 ul 284 Publication
Y061015 Monoclonal Anti Actin (β Sarcomeric) produced in mouse ABM Goods 100ul 1119.3 Y061015 Monoclonal Anti Actin (β Sarcomeric) produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
Y061017 Monoclonal Anti-Actin produced in mouse Antibody ABM Goods 100ul 994.35 Y061017 Monoclonal Anti-Actin produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
Y061018 Monoclonal Anti Actin FITC produced in mouse ABM Goods 100ul 1119.3 Y061018 Monoclonal Anti Actin FITC produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
Y061019 Monoclonal Anti-Actin-Cy3 produced in mouse Antibody ABM Goods 100ul 994.35 Y061019 Monoclonal Anti-Actin-Cy3 produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
Y061026 Monoclonal Anti Actin (Amoeba) produced in mouse ABM Goods 100ul 1119.3 Y061026 Monoclonal Anti Actin (Amoeba) produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
Y061028 Anti-Actin, N-terminal produced in rabbit Antibody ABM Goods 100ul 857.85 Y061028 Anti-Actin, N-terminal produced in rabbit Antibody ABM Goods 100ul 857.85
ASK
Publication
Y090078 Anti actin binding protein 34 (ABP34) Monoclonal ABM Goods 100ul 299.25 Y090078 Anti actin binding protein 34 (ABP34) Monoclonal ABM Goods 100ul 299.25
ASK
Publication
Y090087 Anti-actin binding protein 34 (ABP34) Antibody ABM Goods 100ul 265.65 Y090087 Anti-actin binding protein 34 (ABP34) Antibody ABM Goods 100ul 265.65
ASK
Publication
228-10021-1 Actin Proteins Ray Biotech 10 147 228-10021-1 Actin Proteins Ray Biotech 10 147
ASK
Publication
Y080025 Actin ABM Goods 100ul 147 Y080025 Actin ABM Goods 100ul 147
ASK
Publication
Y102895 Actin, pan Ab 5 ABM Goods 200ug 1584.45 Y102895 Actin, pan Ab 5 ABM Goods 200ug 1584.45
ASK
Publication
Y102896 Actin, pan Ab 5 ABM Goods 100ug 1082.55 Y102896 Actin, pan Ab 5 ABM Goods 100ug 1082.55
ASK
Publication
Y104326 Actin, Chicken Rat ABM Goods 100 ul 800.1 Y104326 Actin, Chicken Rat ABM Goods 100 ul 800.1
ASK
Publication
Y106028 Actin Alpha ABM Goods 250 ul 393.75 Y106028 Actin Alpha ABM Goods 250 ul 393.75
ASK
Publication
Y212605 Actin like 7B ABM Goods 200ul 520.8 Y212605 Actin like 7B ABM Goods 200ul 520.8
ASK
Publication
ON481 Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 ON481 Oncocytoma tissue array, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
T205 Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T205 Lymphoma tissue array, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
Y061010 Monoclonal Anti Actin, β Smooth Muscle produced in mouse ABM Goods 100ul 1119.3 Y061010 Monoclonal Anti Actin, β Smooth Muscle produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
Y061011 Monoclonal Anti Actin, β Smooth Muscle produced in mouse ABM Goods 100ul 1119.3 Y061011 Monoclonal Anti Actin, β Smooth Muscle produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
Y061015 Monoclonal Anti-Actin (β-Sarcomeric) produced in mouse Antibody ABM Goods 100ul 994.35 Y061015 Monoclonal Anti-Actin (β-Sarcomeric) produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
Y061018 Monoclonal Anti-Actin-FITC produced in mouse Antibody ABM Goods 100ul 994.35 Y061018 Monoclonal Anti-Actin-FITC produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
Y061026 Monoclonal Anti-Actin (Amoeba) produced in mouse Antibody ABM Goods 100ul 994.35 Y061026 Monoclonal Anti-Actin (Amoeba) produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
Y090078 Anti-actin binding protein 34 (ABP34) Monoclonal Antibody ABM Goods 100ul 265.65 Y090078 Anti-actin binding protein 34 (ABP34) Monoclonal Antibody ABM Goods 100ul 265.65
ASK
Publication
A00067 Actin, Pan; Clones 1A4 + 5C5.F8.C7 Scy tek 6 ml Ready-to-use 240 A00067 Actin, Pan; Clones 1A4 + 5C5.F8.C7 Scy tek 6 ml Ready-to-use 240
ASK
Publication
A00067.0025 Actin, Pan; Clones 1A4 + 5C5.F8.C7 Scy tek 25 ml Ready-to-use 714 A00067.0025 Actin, Pan; Clones 1A4 + 5C5.F8.C7 Scy tek 25 ml Ready-to-use 714
ASK
Publication
A20067 Actin, Pan; Clones 1A4 + 5C5.F8.C7 Scy tek 2 ml Ready-to-use 147 A20067 Actin, Pan; Clones 1A4 + 5C5.F8.C7 Scy tek 2 ml Ready-to-use 147
ASK
Publication
228-10023-1 Recombinant Human Actin-Like 6A Ray Biotech 2 201 228-10023-1 Recombinant Human Actin-Like 6A Ray Biotech 2 201
ASK
Publication
3598-100 Beta-Actin Antibody Biovision 100 305.235 3598-100 Beta-Actin Antibody Biovision 100 305.235
ASK
Publication
3598-100 Beta Actin Antibody Biovision 100 µg 417.69 3598-100 Beta Actin Antibody Biovision 100 µg 417.69
ASK
Publication
3662-100 Beta-Actin Antibody Biovision 100 301 3662-100 Beta-Actin Antibody Biovision 100 301 Publication
3662-100 Beta Actin Antibody Biovision 100 µg 341.145 3662-100 Beta Actin Antibody Biovision 100 µg 341.145 Publication
3662BP-50 Beta Actin Peptide Biovision 50 ug 143.64 3662BP-50 Beta Actin Peptide Biovision 50 ug 143.64
ASK
Publication
3850-100 Beta Actin Antibody Biovision 100 ug 282 3850-100 Beta Actin Antibody Biovision 100 ug 282
ASK
Publication
3917-100 Beta-Actin Antibody Biovision 100 301 3917-100 Beta-Actin Antibody Biovision 100 301 Publication
Y080025 Actin Antibody ABM Goods 100ul 155.4 Y080025 Actin Antibody ABM Goods 100ul 155.4
ASK
Publication
Y102328 Actin Alpha ABM Goods 250ul 800.1 Y102328 Actin Alpha ABM Goods 250ul 800.1
ASK
Publication
Y102895 Actin, pan Ab-5 Antibody ABM Goods 200ug 1403.85 Y102895 Actin, pan Ab-5 Antibody ABM Goods 200ug 1403.85
ASK
Publication
Y102896 Actin, pan Ab-5 Antibody ABM Goods 100ug 957.6 Y102896 Actin, pan Ab-5 Antibody ABM Goods 100ug 957.6
ASK
Publication
Y102899 Actin, Smooth Muscle Ab 1 ABM Goods 1 ml 1082.55 Y102899 Actin, Smooth Muscle Ab 1 ABM Goods 1 ml 1082.55
ASK
Publication
Y104326 Actin, Chicken Rat Antibody ABM Goods 100 ul 707.7 Y104326 Actin, Chicken Rat Antibody ABM Goods 100 ul 707.7
ASK
Publication
Y106028 Actin Alpha Antibody ABM Goods 250 ul 351.75 Y106028 Actin Alpha Antibody ABM Goods 250 ul 351.75
ASK
Publication
Y107292 Actin BIOTIN ABM Goods 100ug 1082.55 Y107292 Actin BIOTIN ABM Goods 100ug 1082.55
ASK
Publication
Y212605 Actin-like 7B Antibody ABM Goods 200ul 462 Y212605 Actin-like 7B Antibody ABM Goods 200ul 462
ASK
Publication
Y213637 Actin like 7B (mouse) ABM Goods 200ul 520.8 Y213637 Actin like 7B (mouse) ABM Goods 200ul 520.8
ASK
Publication
Y061010 Monoclonal Anti-Actin, β-Smooth Muscle produced in mouse Antibody ABM Goods 100ul 994.35 Y061010 Monoclonal Anti-Actin, β-Smooth Muscle produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
Y061011 Monoclonal Anti-Actin, β-Smooth Muscle produced in mouse Antibody ABM Goods 100ul 994.35 Y061011 Monoclonal Anti-Actin, β-Smooth Muscle produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
Y061012 Monoclonal Anti Actin, β Smooth Muscle FITC produced in mouse ABM Goods 100ul 1119.3 Y061012 Monoclonal Anti Actin, β Smooth Muscle FITC produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
Y061013 Monoclonal Anti-Actin, β-Smooth Muscle-Cy3™ produced in mouse Antibody ABM Goods 100ul 857.85 Y061013 Monoclonal Anti-Actin, β-Smooth Muscle-Cy3™ produced in mouse Antibody ABM Goods 100ul 857.85
ASK
Publication
000800A Actin binding EGFP ABM Goods 250ul 621 000800A Actin binding EGFP ABM Goods 250ul 621
ASK
Publication
228-10173-1 Native Bovine Cardiac Actin Ray Biotech 2 201 228-10173-1 Native Bovine Cardiac Actin Ray Biotech 2 201
ASK
Publication
3598-100 Beta Actin Monoclonal Antibody100 ug Biovision 100 ug 268.38 3598-100 Beta Actin Monoclonal Antibody100 ug Biovision 100 ug 268.38
ASK
Publication
3662-100 Beta Actin Polyclonal Antibody100 ug Biovision 100 ug 212.625 3662-100 Beta Actin Polyclonal Antibody100 ug Biovision 100 ug 212.625 Publication
3662BP-50 Beta Actin Blocking Peptide Biovision 50 ug 145.53 3662BP-50 Beta Actin Blocking Peptide Biovision 50 ug 145.53
ASK
Publication
3662BP-50 Beta Actin Blocking Peptide50 ug Biovision 50 ug 137.025 3662BP-50 Beta Actin Blocking Peptide50 ug Biovision 50 ug 137.025
ASK
Publication
3850BP-50 Beta Actin Blocking Peptide Biovision 50 ug 146 3850BP-50 Beta Actin Blocking Peptide Biovision 50 ug 146
ASK
Publication
3917BP-50 Beta-Actin Blocking Peptide Biovision 50 ug 146 3917BP-50 Beta-Actin Blocking Peptide Biovision 50 ug 146 Publication
Y102328 Actin Alpha Antibody ABM Goods 250ul 707.7 Y102328 Actin Alpha Antibody ABM Goods 250ul 707.7
ASK
Publication
Y102897 Actin, Skeletal Muscle Ab 2 ABM Goods 200ul 928.2 Y102897 Actin, Skeletal Muscle Ab 2 ABM Goods 200ul 928.2
ASK
Publication
Y102898 Actin, Skeletal Muscle Ab 2 ABM Goods 100ul 928.2 Y102898 Actin, Skeletal Muscle Ab 2 ABM Goods 100ul 928.2
ASK
Publication
Y102899 Actin, Smooth Muscle Ab-1 Antibody ABM Goods 1 ml 957.6 Y102899 Actin, Smooth Muscle Ab-1 Antibody ABM Goods 1 ml 957.6
ASK
Publication
Y107292 Actin -BIOTIN Antibody ABM Goods 100ug 957.6 Y107292 Actin -BIOTIN Antibody ABM Goods 100ug 957.6
ASK
Publication
Y213637 Actin-like 7B (mouse) Antibody ABM Goods 200ul 462 Y213637 Actin-like 7B (mouse) Antibody ABM Goods 200ul 462
ASK
Publication
bs-6848R Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody Sepax 100ug Lyophilized 222 bs-6848R Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody Sepax 100ug Lyophilized 222 Publication
ER-14-0084 Goat Anti-Human, Mouse, Rat, Pig Smooth muscle alpha-actin, (N Terminus) Antibodies Ray Biotech 100 μg 353 ER-14-0084 Goat Anti-Human, Mouse, Rat, Pig Smooth muscle alpha-actin, (N Terminus) Antibodies Ray Biotech 100 μg 353
ASK
Publication
MBN481 Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 MBN481 Multiple organ normal tissue array, 48 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
Y061012 Monoclonal Anti-Actin, β-Smooth Muscle-FITC produced in mouse Antibody ABM Goods 100ul 994.35 Y061012 Monoclonal Anti-Actin, β-Smooth Muscle-FITC produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
Y061014 Monoclonal Anti Actin, β Smooth Muscle Alkaline Phosphatase produced in mouse ABM Goods 100ul 1119.3 Y061014 Monoclonal Anti Actin, β Smooth Muscle Alkaline Phosphatase produced in mouse ABM Goods 100ul 1119.3
ASK
Publication
22663 Cell Navigator™ F Actin Labeling Kit *Red Fluorescence* AAT Bioquest 1 kit 231 22663 Cell Navigator™ F Actin Labeling Kit *Red Fluorescence* AAT Bioquest 1 kit 231
ASK
Publication
22664 Cell Navigator™ F Actin Labeling Kit *Red Fluorescence* AAT Bioquest 1 kit 202 22664 Cell Navigator™ F Actin Labeling Kit *Red Fluorescence* AAT Bioquest 1 kit 202
ASK
Publication
3598-100 Beta-Actin Antibody (Clone B11V08) Biovision 100 353.43 3598-100 Beta-Actin Antibody (Clone B11V08) Biovision 100 353.43
ASK
Publication
Y102897 Actin, Skeletal Muscle Ab-2 Antibody ABM Goods 200ul 824.25 Y102897 Actin, Skeletal Muscle Ab-2 Antibody ABM Goods 200ul 824.25
ASK
Publication
Y102898 Actin, Skeletal Muscle Ab-2 Antibody ABM Goods 100ul 824.25 Y102898 Actin, Skeletal Muscle Ab-2 Antibody ABM Goods 100ul 824.25
ASK
Publication
Y102900 Actin, Smooth Muscle Ab 1 (no BSA or Azide) ABM Goods 200ul 1168.65 Y102900 Actin, Smooth Muscle Ab 1 (no BSA or Azide) ABM Goods 200ul 1168.65
ASK
Publication
FBN406a Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed US Biomax 394 FBN406a Multiple organ normal frozen tissue array, 20 organs 40 cores; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
FFE302a Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed US Biomax 394 FFE302a Multiple organ normal frozen tissue array, 15 organs 30 cores; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
MO541 Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed US Biomax 162 MO541 Mouse multiple organ normal tissue array, 24 cases 54 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
NHL802a Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed US Biomax 267 NHL802a Non-Hodgkin's lymphoma tissue array, 42 cases 80 cores, replacing NHL802; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
VLC12 Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed US Biomax 105 VLC12 Lung cancer tissue array, with TNM and grade info, 12 cases 12 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
Y061014 Monoclonal Anti-Actin, β-Smooth Muscle-Alkaline Phosphatase produced in mouse Antibody ABM Goods 100ul 994.35 Y061014 Monoclonal Anti-Actin, β-Smooth Muscle-Alkaline Phosphatase produced in mouse Antibody ABM Goods 100ul 994.35
ASK
Publication
A00001 Actin, Muscle Specific; Clone HHF35 Scy tek 6 ml Ready-to-use 166 A00001 Actin, Muscle Specific; Clone HHF35 Scy tek 6 ml Ready-to-use 166
ASK
Publication
A00001.0025 Actin, Muscle Specific; Clone HHF35 Scy tek 25 ml Ready-to-use 455 A00001.0025 Actin, Muscle Specific; Clone HHF35 Scy tek 25 ml Ready-to-use 455
ASK
Publication
A00002 Actin, Alpha-Smooth Muscle; Clone 1A4 Scy tek 6 ml Ready-to-use 106 A00002 Actin, Alpha-Smooth Muscle; Clone 1A4 Scy tek 6 ml Ready-to-use 106
ASK
Publication
A00002.0025 Actin, Alpha-Smooth Muscle; Clone 1A4 Scy tek 25 ml Ready-to-use 267 A00002.0025 Actin, Alpha-Smooth Muscle; Clone 1A4 Scy tek 25 ml Ready-to-use 267
ASK
Publication
A20001 Actin, Muscle Specific; Clone HHF35 Scy tek 2 ml Ready-to-use 110 A20001 Actin, Muscle Specific; Clone HHF35 Scy tek 2 ml Ready-to-use 110
ASK
Publication
A20002 Actin, Alpha-Smooth Muscle; Clone 1A4 Scy tek 2 ml Ready-to-use 79 A20002 Actin, Alpha-Smooth Muscle; Clone 1A4 Scy tek 2 ml Ready-to-use 79
ASK
Publication
22660 Cell Navigator™ F Actin Labeling Kit *Blue Fluorescence* AAT Bioquest 1 kit 202 22660 Cell Navigator™ F Actin Labeling Kit *Blue Fluorescence* AAT Bioquest 1 kit 202
ASK
Publication
22661 Cell Navigator™ F Actin Labeling Kit *Green Fluorescence* AAT Bioquest 1 kit 202 22661 Cell Navigator™ F Actin Labeling Kit *Green Fluorescence* AAT Bioquest 1 kit 202
ASK
Publication
Y102900 Actin, Smooth Muscle Ab-1 (no BSA or Azide) Antibody ABM Goods 200ul 1035.3 Y102900 Actin, Smooth Muscle Ab-1 (no BSA or Azide) Antibody ABM Goods 200ul 1035.3
ASK
Publication
BN1002a Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed US Biomax 296 BN1002a Multiple organ normal tissue array, 100 cases 100 cores, replacing BN1002; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BN243a Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed US Biomax 105 BN243a Multiple organ normal tissue array, 12 cases 24 cores, replacing BN243; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
bs-0061R-PE-Cy5.5 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-0061R-PE-Cy5.5 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300
ASK
Publication
bs-6848R-Cy3 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Cy3 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-6848R-Cy3 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Cy3 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 Publication
bs-6848R-Cy5 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Cy5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-6848R-Cy5 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Cy5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 Publication
bs-6848R-Cy5.5 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Cy5.5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-6848R-Cy5.5 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Cy5.5 conjugated, Isotype: IgG Sepax 100ug Lyophilized 268
ASK
Publication
bs-6848R-Cy7 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 268 bs-6848R-Cy7 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 268 Publication
bs-6848R-HRP Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, HRP conjugated Isotype: IgG Sepax 100ug Lyophilized 284 bs-6848R-HRP Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, HRP conjugated Isotype: IgG Sepax 100ug Lyophilized 284 Publication
bs-6848R-PE-Cy5 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE-Cy5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-6848R-PE-Cy5 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE-Cy5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 Publication
bs-6848R-PE-Cy5.5 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-6848R-PE-Cy5.5 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE-Cy5.5 conjugated Isotype: IgG Sepax 100ug Lyophilized 300
ASK
Publication
bs-6848R-PE-Cy7 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE-Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 bs-6848R-PE-Cy7 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE-Cy7 conjugated Isotype: IgG Sepax 100ug Lyophilized 300 Publication
FDA808a-1 Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed US Biomax 267 FDA808a-1 Multiple organ normal tissue array, 72 cases 72 cores, replacing FDA808-1; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
FDA999a Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed US Biomax 296 FDA999a Multiple organ normal tissue array, 47 cases 99 cores, replacing FDA999; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed US Biomax 258 GL806a Brain glioblastoma multiforme(GBM) tissue array, 40 cases 80 cores, replacing GL806; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST1503 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 ST1503 Stomach adenocarcinoma tissue array, including TNM and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
T176 Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T176 Brain tumor tissue array, including pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
bs-0061R-FITC Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 bs-0061R-FITC Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 Publication
bs-6848R-Biotin Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Biotin conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 bs-6848R-Biotin Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Biotin conjugated, Isotype: IgG Sepax 100ug Lyophilized 268 Publication
bs-6848R-FITC Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 bs-6848R-FITC Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, FITC conjugated,Isotype: IgG Sepax 100ug Lyophilized 304 Publication
bs-6848R-Gold Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Gold conjugated Isotype: IgG Sepax 100ug Lyophilized 284 bs-6848R-Gold Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Gold conjugated Isotype: IgG Sepax 100ug Lyophilized 284 Publication
FBN407a Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed US Biomax 626 FBN407a Multiple organ normal frozen tissue array, 20 cases 40 cores, replaing FBN407; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FMC409a Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed US Biomax 626 FMC409a Frozen multiple organ cancer tissue array, 20 cases 40 cores, replacing FMC409; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FRA781-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626 FRA781-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FRA781-2 FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626 FRA781-2 FDA standard normal rat multiple organ frozen tissue array, slide two, 26 cases 78 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
LY1001a Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed US Biomax 296 LY1001a Diffuse large-B cell lymphoma tissue array, 100 cases 100 cores, replacing LY1001; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
LY121a Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed US Biomax 185 LY121a Diffuse large B-cell lymphoma tissue array, 12 cases 12 cores, replacing LY121; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
NHL401a Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed US Biomax 296 NHL401a Lymphoma, myeloma and lymph node tissue array, 40 cases 40 cores, replacing NHL401; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 BL1501 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 BO244a Human normal bone and osteosarcoma tissue array, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 BR964 Breast cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
bs-0061R-A350 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0061R-A350 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-0061R-A488 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0061R-A488 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-0061R-A555 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0061R-A555 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-0061R-A647 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-0061R-A647 Rabbit Anti-beta-Actin (Loading Control) Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-6848R-A350 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-6848R-A350 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 350 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-6848R-A488 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-6848R-A488 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 488 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-6848R-A555 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-6848R-A555 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 555 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
bs-6848R-A647 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 bs-6848R-A647 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, Alexa Fluor 647 conjugated,Isotype: IgG Sepax 100ug Lyophilized 323 Publication
BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed US Biomax 267 BS17016a Brain glioblastoma tissue array, including pathology grade, 40 cases 80 cores, replacing BS17016; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 CO1021 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 CO1502 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 CO962 Colon cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 CR1501 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CyFDA1 FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed US Biomax 296 CyFDA1 FDA multiple organ normal tissue array of cynomolgus monkey, 34 organs 99 cores, replacing CyFDA; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296 EN801a Endocrine cancer tissue array, including TNM and clinical stage, 40 cases 80 cores, replacing EN801; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 ES1502 Esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
FBN401 Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed US Biomax 278 FBN401 Normal human multiple organ frozen tissue array (20 organs in duplicate), 20 cases 40 cores; ihc Anti-Actin confirmed US Biomax 278
ASK
Publication
HER2 Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114 HER2 Her-2 IHC Bio-marker control TMA, for CAP proficiency test survey, with breast invasive ductal carcinoma, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114
ASK
Publication
KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 KD1501 Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 LC1502 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 LC961 Lung cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 LV1502 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 LV962 Liver cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429 ME2082a Malignant melanoma tissue array, including TNM and clinical stage, 208 cases 208 cores, replacing ME2082; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 OV961 Ovary tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed US Biomax 185 PA483a Pancreatic cancer tissue array, including TNM and pathology grade, 48 cases 48 cores, replacing PA483; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162 PR484 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 24 cases 48 cores; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296 RE1021 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 102 cases 102 cores; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 RE1503 Rectum cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 SK245 Skin disease tissue array, including TNM, clinical stage and pathology grade, 24 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 SK961 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267 SO751 Leiomyosarcoma and rhabdomyosarcoma tissue array, including TNM and clinical stage, 39 cases 75 cores, replacing BC24021; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 ST962 Stomach cancer tissue array, including clinical stage, TNM and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T125 Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T144 Pancreas cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T214 Skin tumor tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258 UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases 150 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 UT961 Endometrium cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed US Biomax 394 FMC281 Multiple tumor and corresponding normal frozen tissue (14 types) array, 14 cases 28 cores, previously named FMC401; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626 FMC406c Frozen multiple human organ cancer tissue array, including TNM and clinical stage, 40 cases 40 cores; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed US Biomax 626 FMC407b Multiple organ cancer frozen tissue array, including TNM information, 40 cases 40 cores, replacing FMC407; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FRA901-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed US Biomax 626 FRA901-1 FDA standard normal rat multiple organ frozen tissue array, slide one, 15 cases 45 cores, replaced by FRA901a-1; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FRA901-2 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed US Biomax 626 FRA901-2 Normal rat multiple organ (recommended by FDA) frozen tissue array, slide two, 15 cases 45 cores, replaced by FRA901a-2; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296 LV8010 Liver cancer and normal tissue array, with stage and grade info, 80 cases 80 cores, replacing BC03011; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T141a Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed US Biomax 90 T141a Pancreas cancer test tissue array, including TNM and pathology grade, 6 cases 24 cores, replacing T141; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90 T142a Pancreas tumor test tissue array, including TNM and pathology grade, 12 cases 24 cores, replacing T142; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T343 Head & Neck cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90 T385a Malignant melanoma test tissue array, including TNM and clinical stage, 6 cases 24 cores, replacing T385; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267 TH802a Thyroid cancer and adenoma tissue array, including TNM and clinical stage, 80 cases 80 cores, replacing TH802; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
22524 actin-like 8 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 22524 actin-like 8 antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329
ASK
Publication
22954 Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 22954 Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329
ASK
Publication
22955 Actin antibody Source Rabbit Polyconal Ab Species Human Application WB SignalWay Antibody S.A.B 100ul 329 22955 Actin antibody Source Rabbit Polyconal Ab Species Human Application WB SignalWay Antibody S.A.B 100ul 329
ASK
Publication
22959 Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 22959 Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329
ASK
Publication
BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185 BC07014a Kidney cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC07014; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185 BC11012a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing BC11012; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162 BC12011a Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing BC12011; ihc Anti-Actin confirmed US Biomax 162
ASK
Publication
BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258 BR803a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing BR803; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267 BR804a Breast cancer tissue array, including TNM, clinical stage and pathology grade, 40 cases 80 cores, replacing BR804; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267 CO804a Colon cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replcing CO804; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 ES962 Esophageal squamous cell carcinoma tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed US Biomax 858 FDA902-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, 15 cases 45 cores, replaced by FDA902b-2; ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed US Biomax 394 FMC282a Multiple organ cancer frozen tissue array, including pathology grade, 28 cases 28 cores, replacing FMC282; ihc Anti-Actin confirmed US Biomax 394
ASK
Publication
FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed US Biomax 626 FMC405a Multiple organ cancer frozen tissue array, including pathology grade, 40 cases 40 cores, replacing FMC405; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296 GL803a Brain tumor and adjacent normal tissue array, including pathology grade, 80 cases 80 cores, replacing GL803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228 LC726a Lung cancer tissue array, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing LC726; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185 ME481a Melanoma tissue array with normal skin tissues, including TNM and clinical stage, 48 cases 48 cores, replacing ME481; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258 OV803a Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing OV803; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114 PM2-ER ER Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer and IHC results of ER Ki67 PR Her-2, 10 cases 10 cores; ihc Anti-Actin confirmed US Biomax 114
ASK
Publication
PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210 PR483a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing PR483; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296 PR633 Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases 63 cores, replacing PR8010; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296 PR803a Prostate cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PR803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ST1004 Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed US Biomax 258 ST1004 Stomach adenocarcinoma with matched adjacent tissue array, including TNM and pathology grade, 55 cases 100 cores, replacing BC01114; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185 ST483a Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210 ST483b Stomach cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing ST483; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90 T032a Liver tumor tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T032; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
22957 Beta Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329 22957 Beta Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC IF SignalWay Antibody S.A.B 100ul 329
ASK
Publication
3662BP-50 Beta-Actin Blocking Peptide;Appearance Colorless liquid; Accession P02570;Gene ID 60 Biovision 50 ug 145.53 3662BP-50 Beta-Actin Blocking Peptide;Appearance Colorless liquid; Accession P02570;Gene ID 60 Biovision 50 ug 145.53
ASK
Publication
BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185 BC01071a Multiple organ cancer tissue array, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing BC01071; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296 BR963a Breast disease spectrum tissue array, including TNM, clinical stage and pathology grade, 48 cases 96 cores, replacing BR963; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed US Biomax 210 ES481 Esophageal cancer tissue array with matched or unmatched normal adjacent tissues (18 cases 48 cores) with stage and grade info; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90 HN242a Head and neck cancer tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing HN242; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90 T086b Breast cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T086a; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90 T124 Bladder cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T122; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105 T195a Prostate cancer test tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T195; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
CMA241a Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed US Biomax 267 CMA241a Human tumor cell array, 12 cell lines 24 cores, replacing CMA241; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
T291a Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin US Biomax 114 T291a Myeloma tissue array with normal tissue as control, 6 cases 24 cores, replacing T291; ihc Anti-actin US Biomax 114
ASK
Publication
22958 alpha sarcomeric Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 22958 alpha sarcomeric Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329
ASK
Publication
SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228 SF961 Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296 BR10010a Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases 100 cores, replacing BR10010; ihc Anti-Actin confirme US Biomax 296
ASK
Publication
bs-6848R-PE Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE Conjugated , 55kDa; Isotype IgG; Reactivity Human , Mouse , Rat; Application Flow-Cyt(1 20-100), IF(1 50-200) Bioss 100ug Lyophilized 502 bs-6848R-PE Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE Conjugated , 55kDa; Isotype IgG; Reactivity Human , Mouse , Rat; Application Flow-Cyt(1 20-100), IF(1 50-200) Bioss 100ug Lyophilized 502 Publication
bs-6848R-PE-Cy3 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE-Cy3 Conjugated , 55kDa; Isotype IgG; Reactivity Human , Mouse , Rat; Application Flow-Cyt(1 20-100), IF(1 50-200) Bioss 100ug Lyophilized 530 bs-6848R-PE-Cy3 Rabbit Anti-Fascin Actin bundling protein Polyclonal Antibody, PE-Cy3 Conjugated , 55kDa; Isotype IgG; Reactivity Human , Mouse , Rat; Application Flow-Cyt(1 20-100), IF(1 50-200) Bioss 100ug Lyophilized 530 Publication
FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed US Biomax 858 FDA901-1 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide one); ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed US Biomax 858 FDA901-2 FDA Standard Frozen Tissue Array, for therapeutic and diagnostic antibody validation for FDA approval, total 30 organs, 3 individual donors per organ. (slide two); ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858 FRA901a Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation, 45 cases 45 cores, 2 slides set, replacing FRA901; ihc Anti-Actin confirmed US Biomax 858
ASK
Publication
OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105 OV241a Ovary cancer and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing OV241; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
22956 Alpha Smooth Muscle Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329 22956 Alpha Smooth Muscle Actin antibody Source Rabbit Polyconal Ab Species Human Application WB IHC SignalWay Antibody S.A.B 100ul 329
ASK
Publication
BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed US Biomax 742 BRF401 Breast cancer frozen tissue array, with normal tissue, 40 cases 40 cores, Her-2 and ER PR IHC are supplied when purchase; ihc Anti-Actin confirmed US Biomax 742
ASK
Publication
T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T244 Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T388 Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T388 Malignant melanoma test tissue array (4x (2x3)array), including TNM and clinical stage, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed US Biomax 320 LM482a Lymphoma tissue array with normal lymph node tissue as control, 48 cases 48 cores, replacing LM482; ihc Anti-Actin confirmed US Biomax 320
ASK
Publication
BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258 BCN963a Multiple organ tumor and adjacent normal tissue array, including TNM, clinical stage and pathology grade, 81 cases 96 cores, replacing BCN963; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296 BR1505 Breast cancer tissue array, including TNM, clinical stage, pathology grade and IHC markers (ER, PR, Her-2, AR and Ki67) results, 75 cases 150 cores, no overlaps with BR1503 or BR1504; ihc Anti-Actin US Biomax 296
ASK
Publication
CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210 CO484a Colon cancer tissue array with adjacent normal tissues, including TNM, clinical stage and pathology grade, 48 cases 48 cores, replacing CO484; ihc Anti-Actin confirmed US Biomax 210
ASK
Publication
LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed US Biomax 185 LV487 Hepatocellular carcinoma tissue array with matched liver adjacent tissue, including TNM and pathology grade, 16 cases 48 cores,; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296 MS481a Mesothelioma tissue array with normal tissue as control, including TNM and clinical stage, 24 cases 48 cores, replacing MS481; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T014 Stomach cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T024 Esophageal cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T034 Liver cancer test tissue array (4x (2x3) array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T046 Lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T074 Kidney cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T089 Breast cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T095 Endometrium cancer test tissue array (4x (2x3)array), including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90 MC246 Multiple organ tumor with matched adjacent normal tissue array, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing MC244; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267 OV1005a Ovary disease spectrum (ovarian cancer progression) tissue array, including TNM, clinical stage and pathology grade, 100 cases 100 cores, replacing OV1005; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
CO488 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 CO488 Colon adenocarcinoma with matched adjacent colon tissue array, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258 KD961 Kidney tumor tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases 96 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed US Biomax 267 LM801a Lymphoma tissue array with adjacent normal lymph node and spleen tissue as control, 80 cases 80 cores, replacing LM801; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90 T231a Testis tumor tissue array with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T231; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296 BR1005a Breast cancer and matched metastatic carcinoma of lymph node tissue array, including TNM, clinical stage and pathology grade, 50 cases 100 cores, replacing BR1005; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267 FDA808a-2 Multiple organ tumor tissue array with adjacent normal human organs, including TNM, clinical stage and pathology grade, 72 cases 72 cores, replacing FDA808-2; ihc Anti-Actin confirmed US Biomax 267
ASK
Publication
FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed US Biomax 626 FMC402a Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replaced by FMC402b; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626 FMC402b Multiple organ cancer frozen tissue array, with normal tissue, including pathology grade, 40 cases 40 cores, replacing FMC402a; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed US Biomax 626 FMO901-2 Normal mouse multiple organ frozen tissue array, for therapeutic and diagnostic antibody, 15 organs 45 cores, slide 2 of 2 tissue arrays; ihc Anti-Actin confirmed US Biomax 626
ASK
Publication
MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811 MC6163 High-density tissue array of multiple organ tumor and normal tissue, with pathology grade, cllinical stage and TNM, 616 cases 616 cores; ihc Anti-Actin confirmed US Biomax 811
ASK
Publication
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320 MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases 80 cores, replacing MC803; ihc Anti-Actin confirmed US Biomax 320
ASK
Publication
MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382 MC809a Blastoma tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing MC809; ihc Anti-Actin confirmed US Biomax 382
ASK
Publication
ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296 ME803a Malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 80 cases 80 cores, replacing ME803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90 T001a Embryonal tumor test tissue array, with normal tissue as control, including TNM and clinical stage, 6 cases 24 cores, replacing T001; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90 T045c Lung cancer test tissue array, with normal control tissue, including TNM and pathology grade, 12 cases 24 cores, replacing T045; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 T047 Non-small cell lung cancer test tissue array (4x (2x3)array) including TNM, clinical stage and pathology grade, 6 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90 T203a Lymphatic tissue tumor test tissue array, with normal control tissue, 12 cases 24 cores, replacing T203; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 FDA807 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA806, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 FDA808 FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA807, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296 FDA808a FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases 144 cores, for FDA guidelines to test tissue specificity of antibodies; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258 LC817 Lung cancer tissue array with matched lymph node metastatic tissue, including TNM, clinical stage and pathology grade, 40 cases 80 cores; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105 ME241a Multiple malignant melanoma tissue array with adjacent normal skin tissue, including TNM and clinical stage, 12 cases 24 cores, replacing ME241; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228 OV701 Ovary cancer tissue array, with adjacent normal tissue, including TNM, clinical stage and pathology grade, 70 cases 70 cores, replacing BC111110; ihc Anti-Actin confirmed US Biomax 228
ASK
Publication
PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105 PA242a Pancreas cancer tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing PA242; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90 T086a Breast invasive ductal carcinoma test tissue array, with normal tissue, including TNM and pathology grade, 12 cases 24 cores, replaced by T086b; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90 T212a Skin tumor tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T212; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626 FRA901a-1 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-1; ihc Anti-Actin c US Biomax 626
ASK
Publication
FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626 FRA901a-2 Normal rat multiple organ frozen tissue array, for therapeutic and diagnostic antibody validation for FDA approval, 45 cases 45 cores, slide 2 of 2 tissue arrays, replacing FRA901-2; ihc Anti-Actin c US Biomax 626
ASK
Publication
HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296 HN803a Multiple head and neck cancer tissue array with normal tissue, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing HN803; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296 PA805a Pancreas cancer tissue array with adjacent normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases 80 cores, replacing PA805; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90 T112a Ovary cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases 24 cores, replacing T112; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90 T173a Brain cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T173; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
siAP-0002-10-b-actin Positive Control siRNA (beta-actin), HPLC purified, 10 nmol in size AngoiPro 10.00 nmol 278 siAP-0002-10-b-actin Positive Control siRNA (beta-actin), HPLC purified, 10 nmol in size AngoiPro 10.00 nmol 278
ASK
Publication
siAP-0002-25-b-actin Positive Control siRNA (beta-actin), HPLC purified, 25 nmol in size AngoiPro 25.00 nmol 488 siAP-0002-25-b-actin Positive Control siRNA (beta-actin), HPLC purified, 25 nmol in size AngoiPro 25.00 nmol 488
ASK
Publication
siAP-0002-5-b-actin Positive Control siRNA (beta-actin), HPLC purified, 5 nmol in size AngoiPro 5.00 nmol 170 siAP-0002-5-b-actin Positive Control siRNA (beta-actin), HPLC purified, 5 nmol in size AngoiPro 5.00 nmol 170
ASK
Publication
siAP-0007-SetB 3 pairs of specific siRNAs, HPLC purified, with extra 3 control siRNAs, including beta-actin AngoiPro 2.50 nmol 638 siAP-0007-SetB 3 pairs of specific siRNAs, HPLC purified, with extra 3 control siRNAs, including beta-actin AngoiPro 2.50 nmol 638
ASK
Publication
TH242 Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 TH242 Thyroid cancer tissue array with matched adjacent thyroid tissue, including TNM and clinical stage, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
TH809a Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed US Biomax 296 TH809a Thyroid metastatic carcinoma tissue array with normal thyroid tissue as control, 40 cases 80 cores, replacing TH809; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
PRF281 Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed US Biomax 742.35 PRF281 Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases 28 cores; ihc H&E and Anti-Actin confirmed US Biomax 742.35
ASK
Publication
OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258 OR601a Oral squamous cell cancer tissue array with adjacent normal tongue tissue, including TNM, clinical stage and pathology grade, 60 cases 60 cores, replacing OR601; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
PR956 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir US Biomax 487 PR956 Prostate cancer tissue array with matched normal adjacent tissue and metastatic bones, with TNM, Gleason scores, PSA level and survival data, 40 cases 95 cores, replacing PR955; ihc Anti-Actin confir US Biomax 487
ASK
Publication
T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90 T087a Breast cancer test tissue array, with normal tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases 24 cores, replacing T087; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 BL244 Bladder cancer tissue array with matched adjacent bladder tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258 CO802a Colon cancer tissue array with adjacent normal colon tissue, including TNM and clinical stage, 80 cases 80 cores, replacing CO802; ihc Anti-Actin confirmed US Biomax 258
ASK
Publication
CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105 CR245 Cervical cancer tissue array with matched adjacent cervical tissue, including TNM, clinical stage and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 105
ASK
Publication
ES244 Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 ES244 Esophageal squamous cell carcinoma tissue array with matched adjacent esophageal tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90 GL241a Brain tumor tissue array with adjacent normal brain tissue, including pathology grade, 10 cases 24 cores, replacing GL241; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
KD244 Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90 KD244 Kidney clear cell carcinoma tissue array with matched kidney adjacent tissue, including TNM and pathology grade, 12 cases 24 cores; ihc Anti-Actin confirmed US Biomax 90
ASK
Publication
LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed US Biomax 296 LC10010a Lung carcinoma tissue array with normal lung tissue as control, including TNM and clinical stage, 50 cases 100 cores, replacing LC10010; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185 LC488 Lung cancer tissue array with matched adjacent lung tissue, including TNM, clinical stage and pathology grade, 16 cases 48 cores; ihc Anti-Actin confirmed US Biomax 185
ASK
Publication
LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429 LV2091 Liver cancer tissue array with normal liver tissue as control, including TNM, clinical stage and pathology grade, 208 cases 208 cores; ihc Anti-Actin confirmed US Biomax 429
ASK
Publication
ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296 ME1004a Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases 100 cores, replacing ME1004; ihc Anti-Actin confirmed US Biomax 296
ASK
Publication
ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487 ST2091 Stomach cancer tissue array with adjacent normal stomach tissue, including TNM and clinical stage, 208 cases 208 cores, replacing ST2001; ihc Anti-Actin confirmed US Biomax 487
ASK
Publication
T174a Brain tumor tissue array with normal brain tissue as control, including pathology grade, 6 cases 24 cores, replacing T171; ihc Anti-Actin confirmed US Biomax 90 T174a